When was Salvia BioElectronics founded?

Salvia BioElectronics was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Where is Salvia BioElectronics located?

Salvia BioElectronics is headquartered in Eindhoven, Netherlands.

How many employees does Salvia BioElectronics have?

As of Jun 30, 2026, the latest employee count at Salvia BioElectronics is 78.

Is Salvia BioElectronics a funded company?

Salvia BioElectronics is a funded company, having raised a total of $88.4M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on May 22, 2018.

When was the latest funding round of Salvia BioElectronics?

Salvia BioElectronics' latest funding was a $***** Series B round on May 27, 2025, with participation from 9 investors.

Where does Salvia BioElectronics rank among its competitors?

Salvia BioElectronics ranks 1st amongst 24 active competitors, of which 6 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Salvia BioElectronics, which secured $60M in May, 2025.

Who are the top competitors of Salvia BioElectronics?

Salvia BioElectronics' top competitors include ShiraTronics, eNeura and Zosano Pharma. Among them, Salvia BioElectronics secured the most recent funding round in May, 2025.

Salvia BioElectronics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developing bioelectronic solutions for individuals suffering from migraines and other neurological disorders. It aim to eenhance the quality of life for migraine sufferers through its neuromodulation therapy. It has developed a paper-thin implant designed to reduce the frequency and intensity of migraine attacks by delivering gentle electrical pulses to the nerves associated with migraines.

Website: www.salviabioelectronics.com/
Email ID: *****@salvianeuro.com

Key Metrics

Founded Year

2017

Location

Eindhoven, Netherlands

Stage

Series B

Total Funding

$88.4M in 5 rounds

Latest Funding Round

Series B, May 27, 2025, $*****

Investors

BOM & 12 more

Ranked

1^st among 24 active competitors

Employee Count

78 as on Jun 30, 2026

Similar Companies

ShiraTronics & 29 more

View Salvia BioElectronics' full profile

Salvia BioElectronics has raised a total funding of $88.4M over 5 rounds. Its first funding round was on May 22, 2018. Its latest funding round was a Series B round on May 27, 2025 for $*****. 9 investors participated in its latest round. Salvia BioElectronics has 13 institutional investors.

Here is the list of recent funding rounds of Salvia BioElectronics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 27, 2025	8635686	Series B	1964784	1971818	4430044	7846550
Sep 22, 2020	5012859	Conventional Debt	3999720	5653130	2609990	Rijksdienst voor Ondernemend Nederland
Sep 22, 2020	8623594	Series A	2167794	2448418	Panakes Partners & 2 more	BOM & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Salvia BioElectronics's funding rounds and investors

The founders of Salvia BioElectronics is Wim Pollet.

Here are the details of Salvia BioElectronics' key team members:

Wim Pollet: Founder & Chief Medical Officer of Salvia BioElectronics.

View details of Salvia BioElectronics's Founder profiles and Board Members

Salvia BioElectronics' employee count trend

Salvia BioElectronics has 78 employees as of Jun 26. Here is Salvia BioElectronics's employee count trend over the years:

Employee count trend for Salvia BioElectronics

Uncover Salvia BioElectronics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Salvia BioElectronics include ShiraTronics, eNeura and Zosano Pharma. Here is the list of Top 10 competitors of Salvia BioElectronics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Salvia BioElectronics 2017, Eindhoven (Netherlands), Series B	Developing bioelectronic solutions for individuals suffering from migraines and other neurological disorders	$88.4M	Inkef, Invest-NL & 11 others	45/100
2nd	ShiraTronics 2019, Minneapolis (United States), Series B	Developer of a neuromodulating device for treating migraine	$108M	Norwest, Amzak Health & 9 others	44/100
3rd	eNeura 2000, Baltimore (United States), Series D	Developer of a transcranial magnetic stimulation device for pain relief	$70.5M	Camden Partners, New Enterprise Associates ... & 3 others	43/100
4th	Zosano Pharma 2006, Fremont (United States), Deadpooled	Developer of transdermal drug delivery systems for a broad range of therapeutic indications	$147M	New Enterprise Associates, Nomura & 9 others	39/100
5th	Chordate 2005, Kista (Sweden), Unfunded	Developer of a medical device for the treatment of migraine	-	-	34/100
6th	Cefaly Technology 2005, Herstal (Belgium), Acquired	Neurostimulation devices for the treatment of a migraine and other headaches	-	-	34/100
7th	Nocira 2014, Tempe (United States), Series A	Developing a non-invasive migraine treatment device using gentle air pressure	$3.9M	Padda health, AZCrown	33/100
8th	Realeve 2020, Mountain View (United States), Series A	Developer of a device for the treatment of cranial autonomic disorders	$3M	-	30/100
9th	CEFALY Technology 2004, Seraing (Belgium), Acquired	Provider of smart devices to manage migraine pain	-	-	27/100
10th	Brazos Biomedical 2018, Southlake (United States), Acquired	Developing electrostimulation technology for pain management, focusing on migraine treatment	-	-	27/100